Literature DB >> 17658188

Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers.

Sergei Mureev1, Susanna Kushnir, Alexander A Kolesnikov, Reinhard Breitling, Kirill Alexandrov.   

Abstract

The trypanosomatid protozoan Leishmania tarentolae has been extensively used as a model system for studying causative agents of several tropical diseases and more recently as a host for recombinant protein production. Here we analyze the rates of partial or complete deletions of expression cassettes integrated into small ribosomal RNA and tubulin gene clusters as well as into ornithine decarboxylase gene of L. tarentolae. In approximately 60% of cases gene conversion was responsible for the deletion while in the rest of the cases deletion occurred within the expression cassette. We used this observation to design constitutive and inducible expression vectors that could be stably integrated into the genome and subsequently depleted of the antibiotic resistance genes using thymidine kinase or bleomycin resistance genes as negative selection markers. This enabled us to obtain L. tarentolae strains containing constitutive or inducible markerless expression cassettes. Analysis of the markerless strains demonstrated that although stability varied among clones some were stable for as many as 200 generations. We expect that this approach will be useful for the construction of strains carrying multiple expression cassettes for analysis of trypanosomatid pathogenicity mechanisms and overexpression of multi-subunit protein complexes for biochemical and structural studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658188     DOI: 10.1016/j.molbiopara.2007.05.007

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

2.  In vivo imaging of transgenic Leishmania parasites in a live host.

Authors:  Colin J Thalhofer; Joel W Graff; Laurie Love-Homan; Suzanne M Hickerson; Noah Craft; Stephen M Beverley; Mary E Wilson
Journal:  J Vis Exp       Date:  2010-07-27       Impact factor: 1.355

3.  The genetic toolbox for Leishmania parasites.

Authors:  Sigrid C Roberts
Journal:  Bioeng Bugs       Date:  2011-11-01

4.  Spontaneous excision and facilitated recovery as a control for phenotypes arising from RNA interference and other dominant transgenes.

Authors:  Erin A Brettmann; Lon-Fye Lye; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2018-02-03       Impact factor: 1.759

Review 5.  Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Authors:  Sreenivas Gannavaram; Ranadhir Dey; Kumar Avishek; Angamuthu Selvapandiyan; Poonam Salotra; Hira L Nakhasi
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

6.  Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  PLoS Negl Trop Dis       Date:  2016-06-28

7.  Secretory signal peptide modification for optimized antibody-fragment expression-secretion in Leishmania tarentolae.

Authors:  Stephan Klatt; Zoltán Konthur
Journal:  Microb Cell Fact       Date:  2012-07-25       Impact factor: 5.328

8.  Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites.

Authors:  Rubens D M Magalhães; Mariana C Duarte; Eliciane C Mattos; Vivian T Martins; Paula S Lage; Miguel A Chávez-Fumagalli; Daniela P Lage; Daniel Menezes-Souza; Wiliam C B Régis; Maria J Manso Alves; Manuel Soto; Carlos A P Tavares; Ronaldo A P Nagen; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2014-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.